Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of urapidil and doxazosin on heart rate
2005-003660-38Phase 2Completed
- Sponsor
- Medizinische Universitätsklinik
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial comparing Ebrantil arm, Ascalan arm and Placebo arm (3 arms). Primary endpoint: Heart rate at 4 hours following oral drug intake. Started Sep 2005; status: completed.
02
Drugs
urapidildoxazosin
Beyond the preview
Go deeper on 2005-003660-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003660-38.